Gyre Therapeutics (GYRE) Net Margin (2010 - 2026)
Gyre Therapeutics (GYRE) recorded Net Margin of -40.07% in Q2 2026, down 33.20 percentage points from -6.87% a year earlier and down 1.48 percentage points from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Net Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Gyre Therapeutics' Net Margin came in at -15.47% as of Jun 30, 2026, down 17.07 percentage points year-over-year; for FY2025, it was 4.31%, down 7.12 percentage points from FY2024.
- Annual Net Margin has a five-year change of +272.79 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at 11.43% in FY2024 (+93.34 pp), -81.92% in FY2023 (-84.17 pp), 2.25% in FY2022 (+1200.57 pp) and -1198.32% in FY2021 (-929.84 pp).
- The Q2 2026 figure is the lowest quarterly Net Margin since Q4 2023.
- On a year-over-year basis, Net Margin has declined for three consecutive quarters, with an average year-over-year change of +30.81 percentage points over the last eight quarters.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 1839.73 percentage points in Q1 2023, against a drop of 342.59 percentage points in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -38.59% (Q1 2026), -4.63% (Q4 2025) and 11.81% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 32.99% |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | -40.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.07% |
| Mar 31, 2026 | -38.59% |
| Dec 31, 2025 | -4.63% |
| Sep 30, 2025 | 11.81% |
| Jun 30, 2025 | -6.87% |
| Mar 31, 2025 | 12.23% |
| Dec 31, 2024 | -0.36% |
| Sep 30, 2024 | 4.41% |
| Jun 30, 2024 | 13.99% |
| Mar 31, 2024 | 27.72% |
| Dec 31, 2023 | -372.06% |
| Sep 30, 2023 | 12.41% |
| Jun 30, 2023 | 6.32% |
| Mar 31, 2023 | 9.00% |
| Dec 31, 2022 | -29.47% |
| Mar 31, 2022 | -1,830.73% |
| Dec 31, 2021 | -833.16% |
| Sep 30, 2021 | -1,097.78% |
| Jun 30, 2021 | -1,760.42% |
| Mar 31, 2021 | -1,529.52% |
API Access
Gyre Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();